Portfolio company
Almac Diagnostic Services Ltd
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company provides genomic biomarker solutions and companion diagnostic development services for pharmaceutical and biotechnology organisations globally.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Precision for Medicine
This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.
GeneCentric
This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
ACS Biomarker
This company provides biomarker discovery and validation services for cardiovascular disease diagnostics to academic research groups and pharmaceutical industry partners.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Tagomics
This biotechnology company develops a multiomic profiling platform to assist biopharma and diagnostic organisations with disease detection, drug development and therapy selection.
Kinomica Limited
This company develops a phosphoproteomic diagnostic platform to help clinicians and pharmaceutical firms select targeted cancer therapies for individual patients.
Oxford Cancer Biomarkers
This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.
